Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exagen (XGN) Operating Expenses (2018 - 2025)

Exagen (XGN) has disclosed Operating Expenses for 8 consecutive years, with $14.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses rose 19.57% year-over-year to $14.2 million, compared with a TTM value of $52.9 million through Dec 2025, up 13.09%, and an annual FY2025 reading of $52.9 million, up 13.09% over the prior year.
  • Operating Expenses was $14.2 million for Q4 2025 at Exagen, up from $13.2 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $27.3 million in Q4 2022 and bottomed at -$4.2 million in Q4 2023.
  • Average Operating Expenses over 5 years is $15.8 million, with a median of $17.3 million recorded in 2021.
  • The sharpest move saw Operating Expenses tumbled 115.3% in 2023, then soared 383.73% in 2024.
  • Year by year, Operating Expenses stood at $18.9 million in 2021, then soared by 44.26% to $27.3 million in 2022, then tumbled by 115.3% to -$4.2 million in 2023, then skyrocketed by 383.73% to $11.9 million in 2024, then increased by 19.57% to $14.2 million in 2025.
  • Business Quant data shows Operating Expenses for XGN at $14.2 million in Q4 2025, $13.2 million in Q3 2025, and $13.0 million in Q2 2025.